Brought to you by:
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas, USA). Long-term, prospective outcome data after mechanical thrombectomy for deep vein thrombosis (DVT) are lacking. The…
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD, anticipated an informative session on deep vein thrombosis (DVT) at lunchtime Wednesday. The two surgeons co-moderated…
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders. Olivier Espitia (CHU de Nantes, Nantes, France) and colleagues report this main finding from a multicenter…
Study finds anatomic positioning and physical activity type can cause device fatigue in the iliac and iliofemoral veins
A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as well as in iliofemoral veins with hyperextension at the superior ramus of the pubis. Their results…
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results from CLOUT and a propensity score-matched analysis of CLOUT versus ATTRACT—bolster the evidence base for mechanical…
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep vein thrombosis (DVT) versus proximal DVT. The findings were recently published in JAMA Cardiology. The differences…
CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in interventional approaches
This advertorial is sponsored by ACHL. For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for chronic limb-threatening ischemia (CLTI) coalesce into one important truth: the necessity of entering the operating…
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT) population regardless of clot chronicity level, the 2022 annual meeting of the American Venous Forum (AVF)…
Registry data show greater clot chronicity on post-procedure inspection than initially predicted
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more” chronic classification of the condition following intraoperative imaging and thrombus inspection post-procedure, an interim analysis from…
Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter
Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the device was found to significantly improve symptoms and quality of life, while reducing leg swelling. Results…